Results 291 to 300 of about 297,437 (356)

The Impact of Childhood Abuse and Neglect on the Development of Features of Polycystic Ovary Syndrome: A Pilot Study. [PDF]

Womens Health Rep (New Rochelle)
Misra A, Wolfe O, Azziz R.
europepmc   +1 more source

Insulin Resistance in an Underweight Woman with Polycystic Ovary Syndrome: A Case Study. [PDF]

Am J Case Rep
Gacaferri Lumezi B, Lokaj-Berisha V.
europepmc   +1 more source

Women's Health Disorders in a Coeliac Disease Population After Diagnosis—A Nationwide Cohort Analysis

Alimentary Pharmacology &Therapeutics, Volume 61, Issue 10, Page 1603-1611, May 2025.
Women with coeliac disease appear to have higher frequencies of subsequent women's health disorders. Specific conditions vary based on patient age, and clinician awareness is important for longitudinal patient care. ABSTRACT Background There is a female predominance of diagnosed coeliac disease with sex‐related differences in clinical presentation ...
Rama Nanah, Claire Jansson‐Knodell, Arjun Chatterjee, Robana Nanah, M. Housam Nanah, Jehad Almasri, Andrew Ford, Osama Hamid, Ahmed Telbany, Alberto Rubio‐Tapia   +9 more
wiley   +1 more source

Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Abdul Jafar NK, Al Balushi A, Subramanian A, Lee SI, Bennett CJ, Moran LJ, Mousa A, Tay CT, Teede HJ, Mansfield DR.   +9 more
europepmc   +1 more source

Shortcut to the needle in the haystack? Screening for maturity onset diabetes of the young in a population of women with gestational diabetes

Diabetic Medicine, Volume 42, Issue 5, May 2025.
Abstract Aims Pregnant women are occasionally misdiagnosed with gestational diabetes (GDM) when they may have glucokinase monogenic diabetes (GCK‐MODY). Differentiating between GCK‐MODY and GDM is critical due to the distinct treatment strategies required during and after pregnancy.
Sine Knorr, Laura L. Knudsen, Anne L. Madsen, Lene R. Madsen, Lene Mortensen, Henrik H. Thomsen, Lars Peter Sørensen, Per G. Ovesen, Jens Fuglsang, Ulla Kampmann   +9 more
wiley   +1 more source

Redefining Polycystic Ovary Syndrome: Transformative Diagnostic and Management Changes in the 2023 Guidelines. [PDF]

Endocrinol Metab (Seoul)
Hong AR.
europepmc   +1 more source

Efficacy and safety of once‐weekly semaglutide 2.4 mg for weight management in participants from China: A prespecified analysis of the STEP 7 randomized clinical trial

Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2540-2551, May 2025.
Abstract Aim To evaluate the efficacy and safety of semaglutide 2.4 mg versus placebo for weight management in a population of Chinese adults with overweight or obesity. Materials and Methods In STEP 7 (NCT04251156), a double‐blind, phase 3a trial, adults from a predominantly East Asian population with overweight or obesity, with or without type 2 ...
Weijun Gu, Yibing Lu, Xinhua Ye, Guoyue Yuan, Dongmei Liu, Zewei Shen, Ning Zu, Yiming Mu   +7 more
wiley   +1 more source

Analysis of risk factors for depression and anxiety in women with polycystic ovary syndrome. [PDF]

Front Glob Womens Health
Yang Y, Liu L, Hu N, Huo H, Yang X, Wang F.   +5 more
europepmc   +1 more source

Real‐world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database

Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2810-2821, May 2025.
Abstract Aims To understand real‐world tirzepatide utilization and effectiveness (change in weight and body mass index [BMI]) among people without type 2 diabetes (T2D) in the United States. Materials and Methods This retrospective, observational study used Optum's de‐identified Market Clarity database (index date: first‐observed tirzepatide claim ...
Emily R. Hankosky, Chanadda Chinthammit, Alexandra Meeks, Ahong Huang, Jennifer M. Ward, Donna Mojdami, Theresa Hunter Gibble   +6 more
wiley   +1 more source

Pharmacological effects of bile acids on polycystic ovary syndrome via the regulation of chemerin. [PDF]

Chin Med
Tong TT, Bai LB, Yau LF, Li JY, Huang H, Jiang ZH.   +5 more
europepmc   +1 more source